Effect of a Complementary Food Supplement on Growth and Morbidity of Ghanaian Infants (TRIUMF)

Effect of a Complementary Food Supplement on Growth and Morbidity of Ghanaian Infants (6 to 18 Months)

Prevention of malnutrition in infants and children requires access and intake of nutritious food starting at birth with exclusive breastfeeding for the first 6 months of life, breastfeeding in combination with complementary foods from 6-24 months of age, access to clean drinking water and sanitation, access to preventive and curative health care (including prenatal).

In Ghana, the Demographic and Health Survey of 2014 reports rates of stunting, wasting and underweight in children aged 0-59 months are 28%, 14% and 9% respectively. Furthermore, height for age starts dropping from age 4-6 months with children aged 6-23 months being more likely to be stunted (40%) than those below 6 months (4%). Infant and young child feeding data show that for breast-fed children ranging from 6 months through 35 months of age, cereals are predominantly the first foods introduced in the diet (6-8 months of age). As the child grows older, consumption of fruits rich in Vitamin A, other fruits and vegetables and meat, fish, poultry and eggs are reported by the mothers. The Demographic and Health Survey (DHS) found that the proportion of breast fed children aged 6-23 months who received a recommended variety of foods the minimum number of times per day increases with child's age from 28% in children 6-8 months to 50% in children aged 18-23 months.

The study objective is to examine the effect of providing a macro- and micro-nutrient fortified complementary food supplement (KokoPlusTM) on growth and nutritional status of Ghanaian infants.

Study Overview

• Status: Completed
• Conditions: Growth Disorders; Micronutrient Deficiency; Infant Malnutrition; Protein Malnutrition; Morbidity;Infant
• Intervention / Treatment: Dietary supplement: Macro-micronutrient complementary food supplement; Behavioral: Nutrition education; Dietary supplement: A micronutrient powder

Detailed Description

The current study is a cluster randomized single blind intervention design study with three study arms that aimed to examine the effect of providing a macro- and micro-nutrient fortified complementary food supplement (KokoPlus) for a period of 12 months (starting at 6 months of age) on growth and nutritional status of Ghanaian infants at 18 months of age. KokoPlus was formulated using linear programming methodology based on formative and market analysis research findings.

The subjects in this cluster-randomized trial are from communities in three districts of the Central region in Ghana with high rates of moderate and severe acute malnutrition. A total of 38 communities will be randomly assigned to one of three groups using block randomization and another 11 (randomly selected) will be followed cross sectionally as part of a fourth/non intervention group (growth monitoring).

The total sample size is 1204. Sample size calculations were based on two outcome measures: expected reduction in diarrheal morbidity and growth (improvements in height-for-age). Sample size estimates for detecting a 0.5 cm change in height in children provided a caloric and non caloric micronutrient supplement using a design effect of 2, power of 0.80, alpha of 0.05 and assuming an attrition rate of 15%, the required sample size per group was 301.

Mother-infant pairs will be recruited between infant age of 0 to 3 months to participate in monthly nutrition educations sessions and to encourage the women to continue exclusive breast feeding across all three groups. At 6 months of age, infants in each of the three groups were enrolled into the intervention study (upon receipt of informed consent). Data collection involves baseline, midline and endline measurements in the infants at 6, 12 and 18 months of age. In addition, participating mother-infant pairs will be visited weekly for delivery of the supplements and for morbidity monitoring and monthly for the measurement of anthropometry. Anthropometric measurements include: length (Infant/Child Shorr Height Board; Weigh and Measure, LLC ), weight (Seca 874 digital scale ), mid-upper arm circumference (MUAC) (Child MUAC Tape; Weigh and Measure, LLC), subscapular and triceps skinfolds (Holtain skinfold caliper ),head and chest circumference.

Data collection at baseline, midline and endline included one venous sample (3ml) from the infant, HemoCue (Model 301) measurement to assess severe anemia (7 <g/dl) with appropriate referrals as mentioned earlier. Ethylenediaminetetracetic acid (EDTA) Vacutainers (BD ; catalog number 368841) for whole blood and plasma analyses and Trace Element Serum Separator Tube Vacutainers (BD; catalog number 368380) for serum analyses will be used for the sample collection with butterfly needles (21 or 23 gauge). Samples will be immediately placed in a super cooler tube rack and transported back to the lab within five hours where they were processed immediately. Questionnaires will be administered to assess socio-economic status, infant and young child feeding practices, morbidity (past week), household food security along with a 24 hour diet recall. Data was uploaded daily through cellular network, stored on Formhub and then Ona organization servers.

The primary outcome of the study is the change in length for age Z-score from 6 to 18 months of age in infants in the KokoPlus group versus Micronutrient powder group and the Nutrition Education group. Data calculations included estimating anthropometric indices using the WHO (World Health Organization) 2006 growth reference charts using the WHO macro in STATA (18), computing the USAID Food and Nutrition Technical Assistance (FANTA) household insecurity access scores (HFIAS) (19) maternal body mass index (BMI), dietary diversity scores (20), and re-coding variables as required to binary and accounting for missing. Infant anthropometric indices calculated include length for age (LAZ) Z- score, weight for age Z-score (WAZ) and weight for length (WLZ score).

All analyses are intent to treat. Descriptive statistics (means, medians, standard deviations and standard errors) were computed. To verify the randomization assumption, any differences in mean values at baseline across three groups were tested using linear mixed effects regression analyses accounting for clustering. The effect of the supplement (KokoPlus, Micronutrients and Nutrition Education group) on different dependent variables across the intervention period will be tested using mixed effects regression analyses accounting for clustering and repeated measures. The dependent variables tested included change in LAZ between baseline and endline (primary outcome), change in LAZ on a monthly basis (primary outcome 2), change in WAZ, WLZ, serum hemoglobin (unadjusted and adjusted for inflammation), serum ferritin (unadjusted and adjusted for inflammation), serum zinc, serum cortisol, serum insulin growth factor-1 (IGF-1), serum retinol binding protein, C-reactive protein and alpha glycoprotein, prevalence of acute and chronic infection.

A cross-sectional assessment (anthropometry) will be conducted at baseline, midline and endline in 301 infants that are randomly selected from another set of communities (to be identified based on the same community selection criteria). These infants will not be followed longitudinally and the only measurements to be collected include weights and heights. Informed consent procedures will be similar to the three intervention arms. This group is a reference group only and cannot be included in any comparative analysis.

Monitoring of groups that receive a supplement will happen weekly. Compliance will be defined based on the number of supplement packets that are consumed per week. To assure that the mothers are compliant in using the supplement, they will be asked to return the empty supplement packages at the end of the week. Optimal compliance will be defined as consumption of at least 50% of the weekly samples. Supplements will be provided in plastic or paper bags with a clearly labelled household ID (identity number). Compliance and dose response to compliance will be reviewed in existing studies to determine minimum compliance required.

• Study Type: Interventional
• Enrollment (Actual): 1204
• Phase: Not Applicable

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 6 months to 6 months (CHILD)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

1. Non pre-term
2. Singleton birth
3. Exclusively or predominantly breast fed up to time of recruitment
4. Parents planning to live in community for a period of 12 months and willing to participate in the trial for the entire period
5. Receive informed consent from both parents and/or caregivers or from mother alone if single

Exclusion Criteria:

1. Severely anemic (<7 g/dl) (to be referred to Community Health Post (CHP) for routine care on anemia as recommended by Ghana Health Service)
2. Severely malnourished (MUAC <110 mm) (to be referred to CHP with Community-based Management of Acute Malnutrition (CMAM) protocol) and/or use of CMAM protocol or below -2 standard deviations (SD) weight for age Z score

Study Plan

How is the study designed?

Design Details

• Primary Purpose: PREVENTION
• Allocation: RANDOMIZED
• Interventional Model: PARALLEL
• Masking: SINGLE

Number of Arms

4

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
ACTIVE_COMPARATOR: KokoPlus and Nutrition Education; Macro-micronutrient complementary food supplement and Nutrition Education	Dietary supplement: Macro-micronutrient complementary food supplement; This intervention provided a 15 g complementary food supplement called KokoPlus with nutrition education; Behavioral: Nutrition education; This intervention provided nutrition education sessions
ACTIVE_COMPARATOR: Micronutrient and Nutrition Education; A micronutrient powder and Nutrition Education	Behavioral: Nutrition education; This intervention provided nutrition education sessions; Dietary supplement: A micronutrient powder; This intervention provided a 1 g micronutrient powder with nutrition education
ACTIVE_COMPARATOR: Nutrition Education Only; Nutrition Education	Behavioral: Nutrition education; This intervention provided nutrition education sessions
NO_INTERVENTION: Growth Monitoring Only; Growth monitoring

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change in monthly length for age Z-score (monthly LAZ)	Change in length for age Z-score from 6 months to 18 months of age.	Measured on a monthly basis until 18 months of age

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change in Serum Hemoglobin	Change in serum hemoglobin from baseline to endline (6 months to 18 months)	Baseline (6 months), Midline (12 months of age), Endline (18 months of age)
Change in Serum retinol binding protein	Change in serum retinol binding protein from baseline to endline (6 months to 18 months)	Baseline (6 months), Midline (12 months of age), Endline (18 months of age)
Change in serum transferrin receptors	Change from baseline to endline (6 months to 18 months)	Baseline (6 months), Midline (12 months of age), Endline (18 months of age)
Change in serum ferritin	Change from baseline to endline (6 months to 18 months)	Baseline (6 months), Midline (12 months of age), Endline (18 months of age)
Change in serum zinc	Change from baseline to endline (6 months to 18 months)	Baseline (6 months), Midline (12 months of age), Endline (18 months of age)
Change in Weight for age Z-score	This is the change in weight for age Z-score from 6 months to 18 months of age	Measured at baseline and then on a monthly basis for the duration of the intervention (12 months)
Change in Weight for height Z-score	This is the change in weight for length Z-score from 6 months to 18 months of age	Measured at baseline and then on a monthly basis for the duration of the intervention (12 months)
Prevalence of diarrhea	Prevalence of diarrhea over a 12 month period (duration of intervention)	Measured at baseline and then in a weekly surveillance for the duration of the intervention (12 months or 52 weeks)
Prevalence of upper respiratory infections	Prevalence of respiratory infections over a 12 month period (duration of the intervention)	Measured at baseline and then in a weekly surveillance for the duration of the intervention (12 months or 52 weeks)
Change in serum C-reactive protein	Change from baseline to endline (6 months to 18 months)	Baseline (6 months), Midline (12 months of age), Endline (18 months of age)
Change in serum alpha glycoprotein	Change from baseline to endline (6 months to 18 months)	Baseline (6 months), Midline (12 months of age), Endline (18 months of age)
Change in Head Circumference for age	This is the change in head circumference for age from 6 months to 18 months of	Measured at baseline and then on a monthly basis for the duration of the intervention (12 months)
Change in MUAC (Mid Upper Arm Circumference)	This is the change in MUAC for age from 6 months to 18 months of age	Measured at baseline and then on a monthly basis for the duration of the intervention (12 months)
Change in Plasma Amino Acid levels	This is the change in individual plasma amino acids from 6 months to 18 months	Baseline (6 months), Midline (12 months of age), Endline (18 months of age)

Collaborators and Investigators

• Sponsor: Nevin Scrimshaw International Nutrition Foundation
• Collaborators: University of Ghana; Ghana Health Services; Ajinomoto USA, INC.; University of Cape Coast
• Investigators: Principal Investigator: Shibani Ghosh, PhD, Nevin Scrimshaw International Nutrition Foundation; Principal Investigator: Gloria Otoo, PhD, University of Ghana; Principal Investigator: Kwaku Tano-Debrah, PhD, University of Ghana

Publications and helpful links

General Publications

• de Pee S, Bloem MW. Current and potential role of specially formulated foods and food supplements for preventing malnutrition among 6- to 23-month-old children and for treating moderate malnutrition among 6- to 59-month-old children. Food Nutr Bull. 2009 Sep;30(3 Suppl):S434-63. doi: 10.1177/15648265090303S305.
• Pan American Health Organization. Guiding Principles for Complementary Feeding of the Breast Fed Child p37, 2003
• Ghana Statistical Service, Ghana Health Service, ICF Macro Ghana Demographic and Health Survey 2008, Accra, Ghana, p 512, 2009
• Furuta C, Sato W, Murakami H, Suri DJ, Otoo GE, Tano-Debrah K, Ghosh SA. Changes of Plasma Amino Acid Profiles in Infants With a Nutrient-Fortified Complementary Food Supplement: Evidence From a 12-Month Single-Blind Cluster-Randomized Controlled Trial. Front Nutr. 2021 Sep 30;8:606002. doi: 10.3389/fnut.2021.606002. eCollection 2021.

Study record dates

Study Major Dates

• Study Start (ACTUAL): February 1, 2013
• Primary Completion (ACTUAL): February 1, 2015
• Study Completion (ACTUAL): February 1, 2015

Study Registration Dates

• First Submitted: June 5, 2017
• First Submitted That Met QC Criteria: June 7, 2017
• First Posted (ACTUAL): June 8, 2017

Study Record Updates

• Last Update Posted (ACTUAL): March 1, 2018
• Last Update Submitted That Met QC Criteria: February 27, 2018
• Last Verified: February 1, 2018

More Information

Terms related to this study

• Keywords: Complementary food supplement; Protein quality and linear growth; Intervention targeting complementary foods and growth
• Additional Relevant MeSH Terms: Pathologic Processes; Nutrition Disorders; Severe Acute Malnutrition; Malnutrition; Growth Disorders; Infant Nutrition Disorders; Kwashiorkor; Physiological Effects of Drugs; Micronutrients; Trace Elements
• Other Study ID Numbers: Ghana Trial

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO
• IPD Plan Description: There is no plan to share individual participant data to other researchers

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No